Observation Versus Immediate Reinduction for Acute Myeloid Leukemia Patients With Indeterminate Day 14 Bone Marrow Results
Author:
Publisher
Elsevier BV
Subject
Cancer Research,Oncology,Hematology
Reference21 articles.
1. Acute myeloid leukemia: a comprehensive review and 2016 update;De Kouchkovsky;Blood Cancer J,2016
2. Emerging treatments in acute myeloid leukemia: current standards and unmet challenges;Percival;Clin Adv Hematol Oncol,2017
3. Midostaurin, enasidenib, CPX-351, gemtuzumab ozogamicin, and venetoclax bring new hope to AML;Wei;Blood,2017
4. Allogeneic hematopoietic cell transplantation for acute myeloid leukemia: time to move toward a minimal residual disease-based definition of complete remission?;Araki;J Clin Oncol,2016
5. How center volumes affect early outcomes in acute myeloid leukemia;Hahn;Clin Lymphoma Myeloma Leuk,2015
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Evaluating the role of Day 14 bone marrow biopsy and European LeukemiaNet risk classification in predicting overall and relapse‐free survival in acute myeloid leukemia;American Journal of Hematology;2024-07-05
2. MRD-directed and risk-adapted individualized stratified treatment of AML;Chinese Journal of Cancer Research;2023
3. Hypomethylating agent/venetoclax versus intensive chemotherapy in adults with relapsed or refractory acute myeloid leukaemia;British Journal of Haematology;2022-05-04
4. Advances in acute myeloid leukemia;BMJ;2021-10-06
5. What Is the Best Choice and Dose of Anthracycline for Induction Chemotherapy in Acute Myeloid Leukemia?;Acute Leukemias;2021-03-24
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3